Total Raised

$650.68M

Investors Count

34

Deal Terms

5

Funding, Valuation & Revenue

14 Fundings

Innovaccer has raised $650.68M over 14 rounds.

Innovaccer's latest funding round was a Secondary Market for on January 9, 2025.

Innovaccer's valuation in January 2025 was $3,175 - $3,450M.

Innovaccer's latest post-money valuation is from January 2025.

Sign up for a free demo to see Innovaccer's valuations in December 2021, February 2021 and more.

Innovaccer's 2024 revenue was $150T. Innovaccer's most recent revenue is from 2021.

Sign up for a free demo to see revenue data from 2024, 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/9/2025

Secondary Market

$XXM

$X.XXB

((X.XXx))

FY XXXX

3

1/9/2025

Series F

$275M

$3,175 - $3,450M

$X.XXB

((X.XXx))

FY XXXX

8

1/1/2025

Shareholder Liquidity

$XXM

$150T

FY 2024

3

12/15/2021

Series E

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

2/19/2021

Series D

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

Date

1/9/2025

1/9/2025

1/1/2025

12/15/2021

2/19/2021

Round

Secondary Market

Series F

Shareholder Liquidity

Series E

Series D

Amount

$275M

$XXM

$XXM

Investors

Valuation

$XXM

$3,175 - $3,450M

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

$X.XXB

((X.XXx))

FY XXXX

$150T

FY 2024

$X.XXB

((X.XXx))

FY XXXX

$X.XXB

((X.XXx))

FY XXXX

Sources

3

8

3

10

10

Start free trial
New call-to-action

Innovaccer Deal Terms

5 Deal Terms

Innovaccer's deal structure is available for 5 funding rounds, including their Series F from January 09, 2025.

Round

Series F

Series E

Series D

Series B

Series A

Funding Date

$XXM

$XXM

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series F

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series E

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Innovaccer Investors

34 Investors

Innovaccer has 34 investors. M12 invested in Innovaccer's Secondary Market funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/2/2018

1/9/2025

8
Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025)

Corporate Venture

Washington

2/19/2021

1/9/2025

4
Series D, Series E (2021), Series F (2025), Secondary Market (2025)

Venture Capital

California

1/9/2025

1/9/2025

2
Series F, Secondary Market (2025)

Asset/Investment Management

United Kingdom

00/00/0000

00/00/0000

Kaiser Permanente

Subscribe to see more

Corporation

California

00/00/0000

00/00/0000

Danaher Ventures

Subscribe to see more

Corporate Venture

Washington

First funding

3/2/2018

2/19/2021

1/9/2025

00/00/0000

00/00/0000

Last Funding

1/9/2025

1/9/2025

1/9/2025

00/00/0000

00/00/0000

Investor

Kaiser Permanente

Danaher Ventures

Rounds

8
Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025)
4
Series D, Series E (2021), Series F (2025), Secondary Market (2025)
2
Series F, Secondary Market (2025)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Asset/Investment Management

Corporation

Corporate Venture

Location

Washington

California

United Kingdom

California

Washington

Innovaccer Acquisitions

4 Acquisitions

Innovaccer acquired 4 companies. Their latest acquisition was Story Health on September 16, 2025.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/16/2025

Series A

$XXM

$26.6M

Acquired

2

1/21/2025

Subscribe to see more

$XXM

Subscribe to see more

10

3/12/2024

Subscribe to see more

$XXM

Subscribe to see more

10

1/16/2024

Series A

Subscribe to see more

$XXM

$XXM

Subscribe to see more

10

Date

9/16/2025

1/21/2025

3/12/2024

1/16/2024

Investment Stage

Series A

Series A

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$XXM

$XXM

$XXM

$XXM

Total Funding

$26.6M

$XXM

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

New call-to-action

Compare Innovaccer to Competitors

C
CareMoat

CareMoat is a platform that provides data analytics-driven predictive modeling to offer insights for self-funded employers within the healthcare industry. The company assigns Nurse Champions to support employees and facilitates an application for health benefit management. CareMoat serves the self-insured employer sector, focusing on improving healthcare experiences and reducing costs. It was founded in 2019 and is based in Nashville, Tennessee.

Clinithink Logo
Clinithink

Clinithink is a technology company specializing in artificial intelligence for the life sciences and healthcare sectors. The company offers AI solutions that analyze unstructured healthcare data. Clinithink serves the pharmaceutical and healthcare industries with its AI technology aimed at enhancing clinical trial processes, disease diagnosis, and revenue management. It was founded in 2009 and is based in Bridgend, United Kingdom.

Arcadia Logo
Arcadia

Arcadia focuses on big data technology within the healthcare sector. It provides services such as data aggregation, analytics tools, and applications. It serves healthcare providers, payers, and government entities with an emphasis on population health management, care coordination, and decision-making based on data. It was founded in 2002 and is based in Boston, Massachusetts.

Optum Logo
Optum

Optum operates as a health solution and care delivery organization that provides health care services, financial health accounts, and pharmacy benefits management. The company offers care, financial tools for health expenses, and pharmacy services, including home delivery and specialty medications. Optum serves individuals and families, providers and organizations, employers, brokers, and consultants within the health care, financial, and pharmacy sectors. It was founded in 2011 and is based in Eden Prairie, Minnesota.

NextGen Healthcare Logo
NextGen Healthcare

NextGen Healthcare offers integrated health information technology (IT) solutions and data analytics in the healthcare sector. The company has cloud-based electronic health records (EHR) and practice management (PM) software, as well as interoperability, patient engagement, revenue cycle management, and value-based care analytics. NextGen Healthcare serves mid-size to enterprise practices and small practices with specialty-specific content and services. NextGen Healthcare was formerly known as NXGN Management. It was founded in 1974 and is based in Irvine, California.

Applied Research Works Logo
Applied Research Works

Applied Research Works provides a cloud-based platform for data analytics in quality, cost, and risk management for healthcare organizations. The company's solutions aim to support payers, provider organizations, and healthcare partners. It was founded in 2012 and is based in San Ramon, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.